Slilaty Steve N. 4
4 · Sunshine Biopharma, Inc · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Purchase
Series B Preferred Stock
2024-03-04$0.10/sh+100,000$10,000→ 130,000 total
4 · Sunshine Biopharma, Inc · Filed Mar 5, 2024
Series B Preferred Stock